T he initial development of MR venography by Reichenbach et al. 90 laid the foundation for Haacke et al. 42 to apply the principles of MR venography in conventional MRI for broader usage in clinical and research settings. By utilizing magnitude and phase information, both of which are normally acquired from conventional MRI data, susceptibility weighted imaging (SWI) has an enhanced ability to detect microhemorrhages 4, 12, 26 and microvasculature. 26, 27, 41, 92 It is a highly sensitive imaging modality able to depict magnetic substances, such as deoxygenated hemoglobin, with high contrast 42 and to help investigate neurological diseases, 82 grade tumors, 25,63 and assist in determining treatment or prognosis. 18, 26, 37, 70, 71, 115 Over the past years, the SWI technique has found applications in the different fields of neurosurgery, namely neurooncology, vascular neurosurgery, neurotraumatolabbreviatioNs AVM = arteriovenous malformation; CCM = cerebral cavernous malformation; CMB = cerebral microbleed; CVS = cortical vessel sign; DAI = diffuse axonal injury; DBS = deep brain stimulation; DWI = diffusion-weighted imaging; GBM = glioblastoma multiforme; GCS = Glasgow Coma Scale; GPe = external globus pallidus; GPi = internal GP; GRE = gradient-recalled echo; ITSS = intratumoral susceptibility signal; mIP = minimum intensity projection; MRA = MR angiography; MS = multiple sclerosis; PD = proton density; PQ = percentagewise quantification; PWI = perfusion-weighted imaging; SN = substantia nigra; STN = subthalamic nucleus; SWI = susceptibility weighted imaging; TBI = traumatic brain injury; VM = vascular malformation. Susceptibility weighted imaging (SWI) is a relatively new imaging technique. Its high sensitivity to hemorrhagic components and ability to depict microvasculature by means of susceptibility effects within the veins allow for the accurate detection, grading, and monitoring of brain tumors. This imaging modality can also detect changes in blood flow to monitor stroke recovery and reveal specific subtypes of vascular malformations. In addition, small punctate lesions can be demonstrated with SWI, suggesting diffuse axonal injury, and the location of these lesions can help predict neurological outcome in patients. This imaging technique is also beneficial for applications in functional neurosurgery given its ability to clearly depict and differentiate deep midbrain nuclei and close submillimeter veins, both of which are necessary for presurgical planning of deep brain stimulation. By exploiting the magnetic susceptibilities of substances within the body, such as deoxyhemoglobin, calcium, and iron, SWI can clearly visualize the vasculature and hemorrhagic components even without the use of contrast agents. The high sensitivity of SWI relative to other imaging techniques in showing tumor vasculature and microhemorrhages suggests that it is an effective imaging modality that provides additional information not shown using conventional MRI. Despite SWI's clinical advantages, its implementation in MRI protocols is still far from consistent in clinical usage. To develop a deeper appreciation for SWI, the authors here review the clinical applications in 4 major fields of neurosurgery: neurooncology, vascular neurosurgery, neurotraumatology, and functional neurosurgery. Finally, they address the limitations of and future perspectives on SWI in neurosurgery.
ogy, and functional neurosurgery. We here address SWI's current and future applications to make it more accessible to a broader audience of neurosurgeons.
technical aspects of swi t2* gradient-recalled echo
Signal intensity on the MR image is determined by 3 basic parameters: 1) proton density (PD), 2) T1 relaxation time, and 3) T2 relaxation time. The T1 (longitudinal) and T2 (transverse) relaxation times define the way protons revert back to their resting states after the initial radiofrequency pulse.
susceptibility weighted imaging
Susceptibility weighted imaging is a 3D gradient-recalled echo (GRE) sequence that was originally developed for MR venography by exploiting the blood oxygen level-dependent (BOLD) effect and using refined phase information for contrast enhancement in MR images. 41, 90 By extension, SWI involves the combining of magnitude and filtered phase data for further postprocessing in developing minimum intensity projection (mIP) images to depict smaller hemorrhages not seen with T2* imaging ( Fig.  1) . 16, 42 Figure 2 provides a schematic representation of the process of generating an SW image. Table 1 provides a glossary of technical terms used in the production of SW images.
Susceptibility weighted imaging has been tested at various magnetic fields, including 1.5, 3, and 7 T. Higher magnetic fields accentuate magnetic susceptibility effects and hence produce SW images with a higher signal-tonoise ratio, thereby allowing for better visualization of the fine details in brain structures, 73 tumors, 77 and deep and/or smaller vessels. 27, 77 However, ultrahigh field strengths such as > 7 T in SWI 27 may distort the size of brain structures in regions characterized by high iron concentrations. 73 Nonetheless, phase images can be used for differentiating between diamagnetic (that is, calcium) and paramagnetic substances (that is, deoxyhemoglobin, hemosiderin, and ferritin). 113 
literature review methods
Using articles published in the PubMed database, we reviewed the existing SWI literature (Fig. 3) . Publication years for all SWI articles ranged from May 2003 to December 2014. All reviewed articles were in English or were English summaries. The main key words for the search were as follows: 1) susceptibility weighed imaging or magnetic susceptibility; 2) magnetic resonance imaging or gradient recalled echo; 3) neuroradiology or neurosurgery studies. Inclusion criteria were as follows: 1) studies with human participants of any age group and 2) studies involving SWI at any magnetic field strength. Exclusion criteria involved contrast-enhanced SWI or dynamic susceptibility contrast-enhanced perfusion MRI. We selected and reviewed 29 articles in neurooncology, 21 articles in vascular neurosurgery, 17 articles in neurotraumatology, and 14 articles in functional neurosurgery.
swi in Neurooncology
Preliminary research has involved examining the role of SWI as part of the imaging protocol to better detect and/or follow up on cerebral neoplasms. 12, 23, 25, 26, 30, 37, 47, 60, 63, 65, 67, 68, [70] [71] [72] 79, 81, 83, 84, 86, 87, 89, 92, 98, 112, 115, 117, 118 
detecting and diagnosing brain tumors
Numerous studies have shown that SWI is more sensitive than conventional MRI, including T1, 37, 63, 92 contrast-enhanced T1,  63,92,117 T2,  63,92,98 T2*,  65,117 FLAIR,   63,92 PD-weighted, 92 and diffusion-weighted imaging (DWI) 92 in detecting vasculature, internal architecture, or hemorrhage in tumors (Figs. 4 and 5). Small vessels within low-grade gliomas, such as astrocytoma, can be depicted with SWI, 63 and complex tumor vasculature can be found in high-grade gliomas, such as glioblastoma multiforme (GBM). 25 In each case, the additional information helps in tumor grading, 25, 63 which can support neurosurgeons in diagnosis and therapeutic management.
In addition to tumor vasculature, the presence of calcification is important for the clinical diagnosis of brain tumors. Studies have reported that calcification in cerebral neoplasms is correlated with longer patient survival and better prognosis than those for tumors lacking calcification. 54, 75, 78, 81, 118 Although CT is typically used to reveal calcification,
34 SWI can effectively demonstrate intratumoral calcification as well, 23, 70, 76, 112, 118 with hypointensity seen on SW images, which correlates with CT findings (Fig.  4) . 76, 112, 118 In cases in which tumors 67, 84, 86 or medical conditions 68, 98 present similar imaging findings, SWI can help in the dif- ferential diagnosis. For example, SWI can help differentiate between brain abscess and necrotic GBM; a dual hypointense rim sign appears for the brain abscess ( Fig. 6) but not for the GBM. 30, 98 In more complex cases, Lou et al. 67, 68 reported that SWI can detect and differentiate basal ganglia germinoma from subacute lacunar infarct. Currently, some researches are distinguishing brain tumors from multiple sclerosis (MS) plaques by using SWI. Haacke et al. 40 reported on the effectiveness of SWI in detecting iron deposits in MS lesions. SWI could differentiate the vessels from MS lesions by using mIP images to show the continuity of vessels passing through the lesion. 40 The ability of SWI to visualize regions of iron deposition is significant since iron, specifically hemosiderin, is found in the same regions where MS plaques are found. 19, 35, 104 Although hemorrhagic tumors can also form iron deposits within brain parenchyma, MS plaques differ significantly from hemorrhagic tumors in their appearance on SW images given that hem- 2) magnetic coil emits radiofrequency pulses to tip protons into the transverse (x-y) plane; 3) protons will fall out of phase with each other because of magnetic field inhomogeneities; 4) dephasing gradient is applied to first section of readout gradient to strengthen readout signal; 5) magnitude and phase images created; 6) phase image undergoes postprocessing with application of high pass filter and construction of phase mask; and 7) phase mask is multiplied into magnitude image to form SW image with heightened contrast.
orrhagic components would appear as hypointense foci, 100 whereas MS plaques would appear with veins penetrating these plaques 36 and less prominent venous vasculature visible around the MS lesion.
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A few studies have documented the ability of SWI to detect brain metastases. 84, 89, 92, 117 In particular, percentagewise quantification (PQ) has been suggested to help distinguish different brain metastases, which represents a more objective technique in which dot-like or linear lesions on SWI are analyzed. Unfortunately, PQ does not consider the distribution and morphology of lesions found on SW images, which could provide additional information, 89 nor can PQ differentiate between breast carcinoma and bronchial carcinoma, which raises questions about the sensitivity of this technique.
Overall, a major limitation of MRI is that it can only be used for brain tumor detection and not diagnosis since biopsy or histological analysis must be performed in addition to MRI for an accurate diagnosis. 8 Although research concerning SWI and histopathology is small, the SWI findings correlate well with histopathological results. 37, 63, 92, 115 Thus, SWI findings may hold some degree of diagnostic value since lesions seen within tumor boundaries indicate microvasculature and hemorrhagic components verified from pathology.
Aside from its ability to detect tumor characteristics, SWI has been used to objectively grade brain tumors, although the methods in which it was used in grading has varied significantly between studies. Park et al. 83 developed a semiquantitative method of grading cerebral neoplasms using intratumoral susceptibility signals (ITSSs), which are hypointense dot-like or linear structures within tumor boundaries on SWI. Grading is determined by the number of ITSSs depicted within the tumor. 83 ITSSs can differentiate lymphomas from high-grade gliomas, with GBMs producing more prominent ITSSs. 60, 84, 86 However, ITSSs are not as well suited for low-grade gliomas as they are for higher-grade gliomas, 83, 84 and hypointensity levels vary between different tumor types, such as GBM and anaplastic astrocytoma. 83 More importantly, identification of an ITSS is a subjective measure based on the discretion of the neuroradiologist.
Hori et al. 47 described a scheme in which the ratio of hypointensity in the SW image relative to the size of the tumor was used to grade cerebral neoplasms. Hypointensity ratios closely correlated with the World Health Organization (WHO) grading scale of brain tumors and were more accurate than other grading schemes tested, such as the ITSS grading. However, hypointensity ratios represent a semiquantitative method that is ultimately limited by the subjectivity of intra-and interobserver discrepancies in score assignment. 25 Di Ieva et al. 25 have shown a computational fractalbased method applied to SWI analysis as an alternative glioma grading method. The geometric complexity of intratumoral SWI patterns resulting from intratumoral microbleedings and neoplastic vasculature and quantified by means of computational fractal-based analysis was shown to be related to the WHO glioma grade (Fig. 7) . 25 These results suggest that fractal analysis in SWI is a promising method in objective tumor grading since the fractal dimension value is a reliable and useful morphometric image marker to distinguish between low-and high-grade gliomas, 24, 25 as well as other brain tumors, such as brain metastases, meningiomas, and lymphomas (Di Ieva et al., unpublished data, 2015).
Although there is no consensus on tumor grading using SWI, the mentioned studies have demonstrated the potential value of SWI in that context as well as the possibility of developing an objective grading technique with SWI for clinical applications.
In conclusion, SWI provides unique information in patients with brain tumors that cannot be obtained with other MRI sequences. A regular T2 GRE sequence can reveal the presence of hemorrhage or calcium, but it is less sensitive than SWI. Furthermore, SWI can differentiate between calcium and hemorrhage, which is not possible using any other MRI sequences. 113 The distinction between the 2 types of imaging protocols (that is, SWI vs other MRI sequences, such as T2 GRE) is a key point in the differential diagnosis of brain tumors. Other advanced MRI techniques, such as perfusion MRI, may provide better information about microvessel density than SWI; however, perfusion MRI always requires interpretation by taking into account the presence of a susceptibility artifact. The presence of calcium or hemorrhage within the tumor leads to marked cerebral blood volume underestimation; therefore, SWI must be carefully evaluated before interpreting perfusion results.
brain tumor Follow-up and response to treatment
Several studies have demonstrated that SWI can be applied longitudinally to track tumor progression. Prior to treatment, the success of a patient's response to concomitant therapy, including radiotherapy, chemotherapy, and antiangiogenic drugs, can be predicted based on the percentage of SWI hypointensity volume in a T1-weighted contrast-enhancing lesion, in which higher percentages of SWI hypointensity volumes from a contrast-enhancing lesion correspond with a better response to concomitant therapy in patients with newly diagnosed GBM. 72 Patient response to bevacizumab, an angiogenesis inhibitor, could be monitored with SWI to assess whether therapy produced favorable (decreased intratumoral microvasculature) or unfavorable (increased intratumoral microvasculature and the presence of cerebral microbleeds [CMBs]) results. 26, 37 In addition, SWI can detect radiation injury by monitoring the prevalence of CMBs after radiation therapy in patients with glioma 12, 71, 115 or medulloblastoma. 87 Currently, the focus is to develop and validate objective clinical measures, such as PQ 89 and fractal analysis, 26 to reduce the intra-and interobserver variability when assessing a tumor's current state and progression over time.
swi in vascular Neurosurgery
Cerebral vascular malformations (VMs) are disorders characterized by disruptions to normal brain vasculature, which could lead to hemorrhage or capillary function loss. 107 SWI can aid in more accurate detection of the thrombotic region in stroke patients and help depict, differentiate, and monitor abnormal venous flow systems in patients with VMs. The role of SWI in stroke and VMs has been investigated in several studies. 
thrombosis detection
The cortical vessel sign (CVS) can determine the region of thrombosis by comparing the level of deoxygenated hemoglobin to oxygenated hemoglobin in a vessel of the affected hemisphere with vessels in the contralateral hemisphere. 7, 59 SWI can effectively determine the CVS to detect arterial occlusion 49 and the change in CVS preand postadministration of the thrombolytic agent to assess reperfusion levels. 7 Although CVS measurements offer precise information on the thrombotic region, a simpler detection method involves the presence of dilated and hypointense cortical vessels on SW images. 97 The dilated region on SWI correlates with MR angiography (MRA) findings 93 and could be used to monitor occlusion, 57 along with the possibility for hemorrhagic transformation, 57, 64 over time.
monitoring outcome in stroke
A limited collection of studies has examined the ability of SWI to monitor outcome in stroke patients; 6, 7, 49, 56, 64 however, the method of monitoring stroke outcome has varied greatly between studies. Bai et al. 6 have suggested that a greater amount of CMBs on SWI after reperfusion is predictive of a better outcome. Despite this method's simplicity, it has several gaps. Considering that the presence of a CMB typically indicates brain injury, the idea of increased CMBs indicating a better outcome appears questionable. Furthermore, Bai et al. 6 do not provide the range of CMBs that should be found on SW images after reperfusion, which causes ambiguity in determining whether a specific threshold of CMBs should be present on SW images or if the simple appearance of CMBs, regardless of the amount, is indicative of a good outcome.
Mismatches between SWI and DWI is another prognostic marker for stroke, 56 which is based on a technique involving perfusion-weighted imaging (PWI)-DWI mismatches. Considering that PWI-DWI mismatches are still not clearly defined in the neuroradiological field, 13 it is likely that SWI-DWI mismatches would also pose problems of definition since the basis of the SWI-DWI mismatch technique would also be arbitrary among neuroradiologists. Nonetheless, the SWI-DWI mismatch has been recently shown to be a reliable marker for evaluating the ischemic penumbra in stroke patients with cerebral infarction. 69 Measuring changes in the CVS over time was also examined as a potential approach toward stroke outcome prediction; however, no consensus exists regarding its validity. 7, 49 By monitoring changes in pre-and postrecanalization of the CVS, SWI can detect differences in CVS prominence before and after occlusion. 7 Thus, an equal CVS postrecanalization (that is, the appearance of similar veins in both hemispheres) is suggestive of a good clinical outcome, whereas a less prominent CVS (that is, veins in an occluded hemisphere are less prominent than veins in However, most studies 20, 23, 88 have focused on lesion detection in sporadic or familial cerebral cavernous malformations (CCMs), making it difficult to assess the sensitivity of SWI in detecting VMs other than CCMs.
As in T2* MRI, the difference between sporadic and familial CCM on SWI is the appearance of one lesion versus numerous lesions, respectively (Fig. 8) . 20 The Zabramski classification 114 is a common system used to identify familial CCMs based on 4 types of lesion patterns seen in T1, T2, and GRE images. One study 21 has attempted to match findings on SW images with the Zabramski classification; however, this approach requires further research as numerous lesions could not be classified into distinct categories for the GRE images.
Current research suggests that SWI may become an effective method for VM detection. SWI can distinguish high-flow from low-flow VMs. 52, 53 Moreover, in more complex cases, SWI can help diagnose specific high-flow VMs, such as arteriovenous malformations (AVMs; Fig. 9 ), 53 and low-flow VMs, including CCM, 20, 23, 88 brain capillary telangiectasia, 28 or Sturge-Weber syndrome. 48, 110 Most importantly, the findings from SWI, especially at ultrahigh fields (that is, 7 T), 29 are shown to correlate with histopathological studies. 88 SWI is a promising technique since its findings correlate well with "gold-standard" techniques for detecting VMs, including digital subtraction angiography and time-of-flight MRA. 52 However, SWI in its present state cannot replace contrast-enhanced imaging, as the cortical venous reflex in dural arteriovenous fistulas appears to be missing 62 while leptomeningeal abnormalities in SturgeWeber syndrome are not clearly depicted on SWI. 48 
swi in Neurotraumatology
SWI is an effective imaging method that can detect microhemorrhage in the white matter of patients with traumatic brain injury (TBI) 4, 42 and can help dichotomize patients with diffuse axonal injury (DAI) as hemorrhagic or nonhemorrhagic. 101 The ability to distinguish hemorrhagic from nonhemorrhagic DAI is beneficial since treatment, outcome, and prognosis will differ between these 2 conditions. In the last few years, several articles have been published on the application of SWI in patients with TBI. 5, 9, 10, 15, 17, 18, 33, 45, 46, 51, 58, 82, 94, 95, [99] [100] [101] 
lesion detection
Small punctate lesions seen on MR images are sugges- tive of DAI 32 and are commonly found in the brainstem and corpus callosum in postmortem analyses. 2 Numerous studies have shown the sensitivity of SWI in lesion detection compared with other imaging techniques, including CT, 10, 15, 94 15, 33, 94, 95 The high sensitivity of SWI allows for the detection and monitoring of smaller (< 5 mm) CMBs. 46 In particular, SWI is more sensitive in detecting lesions in the brainstem and corpus callosum, 17, 33, 45, 82, 100 thereby providing neurosurgeons with more information on the extent of injury, 94 which in turn helps to better predict edema and infarction, 100 which is useful for prognostication. In essence, the mere presence of lesions in the brainstem and corpus callosum on SW images correlates with neuropathological findings outlined by Adams et al. 2 The ability of SWI to match pathological findings in DAI lends credibility to the technique and suggests that it can be a necessary and sufficient imaging modality to diagnose DAI.
Although SWI can detect a global increase in brain lesions, it is more significant that the number and volume of these lesions correlate with Glasgow Coma Scale (GCS) scores 9, 18, 33, 82, 99 (Fig. 10 ). In particular, brainstem lesions correlate well with both GCS scores and the presentation of neurological deficits, including consciousness, disorientation, and visual field disturbances.
51,82 outcome prediction
Various studies have demonstrated the effectiveness of SWI in outcome prediction using SWI for hemorrhage grading, 51 the dichotomization of patients with and those without CMBs, 29, 33 or the detection of a greater number and volume of lesions. 5, 9, 94, 95, 99 Despite having various SWI methods for outcome prediction, the current state of research has yet to reveal which method would exhibit the highest accuracy and specificity in predicting outcome and recovery.
In terms of outcome prediction with respect to clinical variables, such as surgical intervention and length of intubation, the number and volume of lesions detected on SWI was positively correlated with clinical severity. 9 Lesion number and volume on SWI have respectable accuracy (approximately 78%) when predicting outcome; however, the combination of clinical variables, such as GCS scores and coma duration, with SWI information provided an additive effect with higher accuracy and fewer false-positives and false-negatives in general than the use of either clinical variables or SWI data alone. 99 Another study showcasing the importance of combining information for better outcome prediction involved the use of SWI with FLAIR to predict clinical variables, such as time spent in the intensive care unit and total number of days of hospitalization, in children. 17 More specifically, patients with lesions on both SWI and FLAIR typically had poorer outcomes than patients with lesions found solely on SWI. 17 Although these studies offer promising evidence for outcome prediction using SWI, an overarching limitation is the lack of consensus in defining "outcome." Most studies assessed neurological status using either the Glasgow Outcome Scale 15, 51, 82, 99 or Pediatric Cerebral Performance Category Scale (PCPCS). 18, 94 There is preliminary evidence that SWI is useful in predicting outcome through cognitive factors as well, including IQ, attention, and verbal reasoning. 5, 9, 95 Finally, one study 5 has reported that lesions to the brainstem and basal ganglia hold the strongest predictive power in determining neuropsychological outcome.
Although SWI is effective in outcome prediction, it is important to acknowledge that this imaging technique, in its current state, can only act as a complementary tool. The best predictor still involves clinical variables; 5, 18, 58 however, SWI could become the next best predictor when clinical variables, such as coma duration, are difficult to assess.
swi in Functional Neurosurgery
SWI can effectively assist the neurosurgeon in providing more information for anatomical localization in functional neurosurgery, thereby providing safer and more efficient procedures for deep brain stimulation (DBS), 1, 74, 80 as well as for Gamma Knife radiosurgery (for example, targeting nuclei of the thalamus for tremor treatment). 102 The potential advantages of SWI in DBS and Gamma Knife radiosurgery, among other procedures, have led to a significant number of studies further examining the role of SWI in applications for functional neurosurgery. 1, 14, 22, 39, 43, 44, 55, 66, 74, 80, 91, 103, 106, 116 Fig. 10. Representative case of severe TBI in a 22-year-old patient who suffered a motor vehicle collision, GCS Score 3 on admission, in which SWI revealed diffuse bleeding in the white-gray matter junction, corona radiata, centrum semiovale, basal ganglia, and brainstem. The microbleedings in the brainstem were not visualized on CT and other MRI sequences.
deep brain stimulation
DBS works by targeting specific nuclei of the basal ganglia, such as the subthalamic nucleus (STN) or internal globus pallidus (GPi). 61 DBS surgery requires MRI-guided stereotactic localization, microelectrode mapping, and intraoperative testing to determine optimal voltage thresholds. 96 Complications can arise when coordinates obtained from MR images and atlas mapping do not correspond, leading to malpositioning of electrodes. 85 SWI can be used to clearly visualize the red nucleus, 103 substantia nigra (SN), globus pallidus (GP), subthalamic nucleus (STN), 1 along with various brainstem nuclei, such as the inferior olive and spinal trigeminal nucleus 22 (based on differential iron deposition), which can assist in presurgical planning and diagnostic purposes. The ability of SWI to depict the venous network around the brainstem will provide neurosurgeons with even more information to plan surgical approaches in the infratentorial regions, as well as decide the final placement of electrodes, which can help prevent intracerebral hemorrhage. 14, 71 Imaging of healthy volunteers and patients requiring DBS showed that SWI, relative to T1, T2, T2*, and PDweighted imaging, was most effective in depicting the STN. 80 SWI using ultrahigh magnetic fields (7 T) can provide even greater contrast between midbrain structures, allowing for differentiation between internal and external portions of the globus pallidus (GPi and GPe), along with the development of 3D SWI maps outlining the location of the SN, STN, GPi, and GPe, which can aid in electrode placement and stimulation management. 1 The benefits of applying SWI at 7 T are further observed with the delineation of blood vessels of varying sizes, including small venules as thin as 250 μm 77 and submillimeter cerebellar veins such as the central vein of the dentate nucleus. 27 
limitations of swi
Although SWI has been shown to be superior to conventional MRI in vessel imaging and hemorrhagic detection, the technique still has some limitations. Several studies have described the long acquisition times required to obtain an SW image, 15, 31, 33, 50, 57, 65, 66, 80, 92, 99, 100, 115 which makes movement artifacts likely to occur because of patient discomfort, which subsequently distorts SWI findings.
31,57,92,100
The use of higher magnetic fields in SWI protocols at 3 T or 7 T 15 and the application of parallel acquisition when obtaining SWI data are promising methods suggested to greatly reduce the required imaging time; 31, 92, 99 however, further reduction in acquisition times remains a major priority.
SWI is prone to air-tissue artifacts with phase data 22, 50, 92, 108, 111 and susceptibility artifacts, such as bone structures, 105 which can distort image findings. Furthermore, the sliceby-slice method, which neuroradiologists and computer programs use in counting the number of lesions found in SW images, may lead to an exaggeration of the number of lesions or a misinterpretation of blood vessels as lesions, spanning over many slices. 100, 108 Few studies have examined the relationship between SWI findings and histopathology. Lesions found on SWI can only be assumed to represent CMBs 4,18,28 as verification from current histopathological studies is lacking. The small number of studies 37, 79, 92, 115 that have examined the link between these 2 variables have shown SWI confirming the results of histopathological analysis; however, findings have been limited to cerebral neoplasms. In some cases, correlations between SWI findings and histopathology are unlikely to be achieved given the benign nature of the disease, such as brain capillary telangiectasia, and biopsies will rarely be done to confirm SWI findings. 28 However, in other cases in which the disease is fatal, it is important to verify the findings seen on SWI as lesions assumed to be CMBs could just as well represent cerebrovascular disease, hemorrhagic microangiopathy due to aging, or even fat. 20, 38 conclusions and Future perspectives Although great advances have been made since the introduction of SWI, 41 there are still many aspects in which SWI can improve and many fields in which SWI's applications can expand. Developing baselines 111 and recording isointensity values with respect to tumors or anatomical structures from SW images, such as the SN or GP, can help monitor disease states over time. Future SWI research should aim to decrease the intra-and interobserver variability in tumor boundary determination using objective measures, such as fractal analysis, as well as correlate histological findings with SWI data. 24, 26 Finally, research should focus on standardizing postprocessing procedures of SW images and correlating neuroradiological results with clinical symptoms to determine biomarkers helpful for prognosis. 24, 26 In essence, SWI is not limited to lesion detection but can be applied toward demonstrating treatment response in neurooncology, monitoring stroke recovery in vascular neurosurgery, and predicting outcomes in neurotraumatology, as well as better anatomical localization in functional neurosurgery and Gamma Knife radiosurgery. SW images can be fused in intraoperative neuronavigation as well, giving more intraoperative details on the venous vasculature, offering more information for stereotactic biopsies and planning of surgical approaches (Fig. 11) . Neurosurgeons must be aware of the pros and cons of such a technique, adding it to their armamentarium whenever required. Advances in SWI research will eventually expand the role of SWI in neurosurgery.
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